CORC  > 中南大学
An allopurinol‐controlled, multicenter, randomized, double‐blind, parallel between‐group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia
Huang, Xinfang; Du, Hui; Gu, Jieruo; Zhao, Dongbao; Jiang, Lindi; Li, Xinfu; Zuo, Xiaoxia; Liu, Yi; Li, Zhanguo; Li, Xiangpei
刊名International Journal of Rheumatic Diseases
2014
卷号17期号:6页码:679-686
关键词allopurinol febuxostat gout hyperuricemia
ISSN号1756-185X
DOI10.1111/1756-185X.12266
URL标识查看原文
WOS记录号WOS:000344362300013
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3329204
专题中南大学
作者单位1.[Huang, Xinfang
2.Bao, Chunde
3.Du, Hui] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Shanghai 200001, Peoples R China.
推荐引用方式
GB/T 7714
Huang, Xinfang,Du, Hui,Gu, Jieruo,et al. An allopurinol‐controlled, multicenter, randomized, double‐blind, parallel between‐group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia[J]. International Journal of Rheumatic Diseases,2014,17(6):679-686.
APA Huang, Xinfang.,Du, Hui.,Gu, Jieruo.,Zhao, Dongbao.,Jiang, Lindi.,...&Bao, Chunde*.(2014).An allopurinol‐controlled, multicenter, randomized, double‐blind, parallel between‐group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.International Journal of Rheumatic Diseases,17(6),679-686.
MLA Huang, Xinfang,et al."An allopurinol‐controlled, multicenter, randomized, double‐blind, parallel between‐group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia".International Journal of Rheumatic Diseases 17.6(2014):679-686.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace